Expression of FGF-2 and osteopontin in non-small cell lung cancer

Journal of Central South University (Medical Sciences)

Volumn 34, Issue 11, 2009, Pages 1114-1119

  Li, Ting ^a,b   Zhou, Jianhua ^a   Deng, Zhenghao ^a   Fu, Chunyan ^a   Jiang, Haiying ^a   Gao, Zhenqin ^a   Wang, Jinsheng ^b   Ren, Hongzheng ^a   Wang, Peng ^a  

^a Central South University   (China)

^b CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

Fibroblast growth factor 2; Non small cell lung cancer; Osteopontin

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; OSTEOPONTIN; SPP1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OSTEOPONTIN; RNA, MESSENGER;

EID: 73349090918     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics [J]. CA Cancer J Clin, 2005,55(1):10-30.
2. Fontijn D, Duyndam M C, van Berkel M P, et al. CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1 F6 human melanoma cells [J]. Br J Cancer, 2006, 94 (11): 1627-1636.
3. Wai P Y, Kuo P C. Osteopontin: regulation in tumor metastasis [J]. Cancer Metastasis Rev,2008,27 (1): 103-118.
4. Mountain C F. Revisions in the International System for Staging Lung Cancer [J] Chest, 1997, 111 (6): 1710-1717.
5. Faridil A, Rudlowskil C, Biesterfeld S, et al. Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer[J]. Pathol Res Pract,2002, 198 (1): 1-5.
6. Okada-Ban M, Thiery J P, Jouanneau J. Fibroblast growth factor-2 [J]. Int J Biochem Cell Biol, 2000,32(3): 263-267.
7. GUO Kejun, ZHANG Yi. The study of bFGF expression in cervical cancer and its effect on cell proliferation [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2008, 24(3): 210-212.
8. XIAO Desheng, CAO Huiqiu, DENG Zhenghao, et al. Effect of FGF-2 on survivin and subcellular location of Smac in human small cell lung cancer cell NCI-H446 [J]. J Cent South Univ. Med Sci,2008,33 (8):705-711.
9. YU Min, LI Shuyu, YU Zhan, et al. Clinical significance of heparanase and basic fibroblast growth factor expression in human non - small cell lung cancer [J]. Chin J Pathol,2005, 34 (1):36-41.
10. Rittling S R, ChamberA F. Role of osteopontin in tumor progression [J]. Br J Cancer, 2004,90(10):1877-1881.
11. Allan A L, George R, Vantyghem S A, et al. Role of the integrin binding protein osteopontin in lymphatic metastasis of breast cancer [J]. Am J Pathol, 2006, 169 (1):233-246.
12. Irby R B, McCarthy S M, Yeatman T J. Osteopontin regulates multiple functions contributing to human colon cancer development and progression [J]. Clin Exp Metastasis, 2004, 21 (6):515-523.
13. Hu Z, Lin D. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer [J]. Clin Cancer Res, 2005,11 (13): 4646-4652.
14. Leali D, Dell' Era P, Stabile H, et al. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis [J]. J Immunol, 2003, 171 (2):1085-1093.